Screener
Veracyte VCYT Business Segments — Net Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Other income, net | 7,328 | 4,524 |
| Income before income taxes | 29,974 | 7,428 |
| Income tax provision | 1,267 | 381 |
| Net income | $28,707 | $7,047 |
| Earnings per share: | ||
| Basic | $0.36 | $0.09 |
| Diluted | $0.35 | $0.09 |
| Shares used to compute earnings per common share: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's business segments — net income?
- Veracyte (VCYT) reported business segments — net income of $28.71M in Q1 2026.
- How has Veracyte's business segments — net income changed year-over-year?
- Veracyte's business segments — net income increased by 307.4% year-over-year, from $7.05M to $28.71M.
- What is the long-term trend for Veracyte's business segments — net income?
- Over 3 years (2022 to 2025), Veracyte's business segments — net income has grown at a 22.0% compound annual growth rate (CAGR), from -$36.56M to $66.35M.
- What does business segments — net income mean?
- This metric represents the final bottom-line profitability of the reportable segment after all operating expenses, taxes, and non-operating items have been deducted from its revenue. It serves as the primary indicator of the segment's financial health and its ability to generate sustainable returns for the organization. Investors use this to evaluate the segment's contribution to overall corporate earnings.
Ask your AI about Veracyte's business segments — net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude